【结 构 式】 |
【分子编号】26862 【品名】4-(benzyloxy)-2,6-pyridinediamine 【CA登记号】 |
【 分 子 式 】C12H13N3O 【 分 子 量 】215.25484 【元素组成】C 66.96% H 6.09% N 19.52% O 7.43% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(IV)Sylilated hydroxymethylpyridine (I) was condensed with ethyl 4-fluorobenzoate (II) in the presence of sodium hemamethyldisilazide to produce the silyloxy ketone (III). Subsequent reaction of (III) with diaminopyrimidine (IV) in the presence of H2SO4 in refluxing dimethoxyethane yielded the title pyrrolopyridine.
【1】 Henry, J.R.; Rupert, K.C.; Dodd, J.H.; Turchi, I.J.; Wadsworth, S.A.; Cavender, D.E.; Schafer, P.H.; Siekierka, J.J.; Potent inhibitors of the MAP kinase p38. Bioorg Med Chem Lett 1998, 8, 23, 3335. |
【2】 Dodd, J.H.; Henry, J.R.; Rupert, K. (Ortho-McNeil Pharmaceutical, Inc.); Substd. pyrrolopyridines useful in the treatment of inflammatory diseases. WO 9847899 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 22829 | 4-([[tert-butyl(dimethyl)silyl]oxy]methyl)pyridine; tert-butyl(dimethyl)silyl 4-pyridinylmethyl ether | C12H21NOSi | 详情 | 详情 | |
(II) | 22830 | ethyl 4-fluorobenzoate | 451-46-7 | C9H9FO2 | 详情 | 详情 |
(III) | 22831 | 2-[[tert-butyl(dimethyl)silyl]oxy]-1-(4-fluorophenyl)-2-(4-pyridinyl)-1-ethanone | C19H24FNO2Si | 详情 | 详情 | |
(IV) | 26862 | 4-(benzyloxy)-2,6-pyridinediamine | C12H13N3O | 详情 | 详情 |
Extended Information